Page last updated: 2024-10-24

verapamil and Hypogalactia

verapamil has been researched along with Hypogalactia in 2 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Hypogalactia: A condition of less than normal MILK secretion.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fearrington, EL1
Rand, CH1
Rose, JD1
Gluskin, LE1
Strasberg, B1
Shah, JH1

Other Studies

2 other studies available for verapamil and Hypogalactia

ArticleYear
Hyperprolactinemia-galactorrhea induced by verapamil.
    The American journal of cardiology, 1983, May-01, Volume: 51, Issue:8

    Topics: Female; Galactorrhea; Humans; Lactation Disorders; Pregnancy; Prolactin; Verapamil

1983
Verapamil-induced hyperprolactinemia and galactorrhea.
    Annals of internal medicine, 1981, Volume: 95, Issue:1

    Topics: Adult; Female; Galactorrhea; Humans; Lactation Disorders; Pregnancy; Prolactin; Verapamil

1981